Skip to Main Content
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

Geoffrey Miller

MD, FRCP, FRACP, MPhil, MA, MBChB
Professor Emeritus of Pediatrics (Neurology); Clinical Director Yale Pediatric Neurology, Co-Director Yale/MDA Pediatric Neuromuscular Clinic

Contact Information

Geoffrey Miller, MD, FRCP, FRACP, MPhil, MA, MBChB
Download CV

Related Links

Research Summary

Geoffrey Miller, M.B., Ch.B., investigates neuropsychological function in the muscular dystrophies. In addition, he investigates and reports on the bioethical issues that surround the care and management of the disabled child. This includes end-of-life issues, extreme prematurity, and the neurologically impaired infant.

Specialized Terms: Outcome studies; Follow-up of high risk premature and full term infants; Bioethics; Pediatric neuromuscular disorder; Neurodevelopmental disorder; Cerebral palsy; Extreme prematurity

Research Interests

Bioethics; Cerebral Palsy; Infant, Newborn; Infant, Premature; Muscular Dystrophies; Neurology; Neuromuscular Diseases; Pediatrics; Premature Birth; Infant, Extremely Premature; Health Care

Selected Publications

  • Addressing the problem of ADHD medication as neuroenhancementsGraf W, Miller G, Nagel S. Addressing the problem of ADHD medication as neuroenhancements. Expert Review Of Neurotherapeutics 2014, 14: 569-581. PMID: 24738763, DOI: 10.1586/14737175.2014.908707.
  • Author Response.Graf W, Nagel S, Osnabruck N, Epstein L, Miller G, Larriviere D. Author Response. Neurology 2013, 81: 1558-9. PMID: 24303531.
  • Pediatric neuroenhancementRothman S, Graf W, Nagel S, Epstein L, Miller G, Larriviere D. Pediatric neuroenhancement. Neurology 2013, 81: 1558-1559. PMID: 24145884, DOI: 10.1212/01.wnl.0000437277.02794.3a.
  • Pediatric neuroenhancementGraf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D. Pediatric neuroenhancement. Neurology 2013, 80: 1251-1260. PMID: 23486879, DOI: 10.1212/wnl.0b013e318289703b.
  • Pediatric BioethicsMiller G (Ed). Pediatric Bioethics. New York, Cambridge University Press, 2009 .
  • Futility by any other name.Miller G. Futility by any other name. The Texas 10 day rule. Journal of Bioethical Inquiry 2008; 5: 265-270
  • Futility revisited. Reply to Mark Mercurio.Miller G. Futility revisited. Reply to Mark Mercurio. Hastings Center Report 2008; Jan-Feb: 7
  • Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental DelayMaricich SM, Azizi P, Jones JY, Morriss MC, Hunter JV, Smith EO, Miller G. Myelination as Assessed by Conventional MR Imaging is Normal in Young Children with Idiopathic Developmental Delay. American Journal Of Neuroradiology 2007, 28: 1602-1605. PMID: 17846220, PMCID: PMC8134387, DOI: 10.3174/ajnr.a0602.
  • Lesion regression.Airewele G, Miller G, McCluggage C, Chintagumpala M. Lesion regression. Journal Of Neurosurgery 2007, 107: 80-1; author reply 81. PMID: 17644928, DOI: 10.3171/PED-07/07/080.
  • Ten days in Texas.Miller G. Ten days in Texas. The Hastings Center Report 2007, 37: 1 p following 56. PMID: 17844925.
  • Extreme Prematurity. Practices, Bioethics, and the LawMiller G. Extreme Prematurity. Practices, Bioethics, and the Law. New York, Cambridge University Press, 2007
  • Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.Lu CW, Lin JH, Rajawat YS, Jerng H, Rami TG, Sanchez X, DeFreitas G, Carabello B, DeMayo F, Kearney DL, Miller G, Li H, Pfaffinger PJ, Bowles NE, Khoury DS, Towbin JA. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome. Journal Of Medical Genetics 2006, 43: 653-9. PMID: 16571646, PMCID: PMC2564587, DOI: 10.1136/jmg.2006.040816.
  • Cerebral folate deficiency with developmental delay, autism, and response to folinic acid.Moretti P, Sahoo T, Hyland K, Bottiglieri T, Peters S, del Gaudio D, Roa B, Curry S, Zhu H, Finnell RH, Neul JL, Ramaekers VT, Blau N, Bacino CA, Miller G, Scaglia F. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 2005, 64: 1088-90. PMID: 15781839, DOI: 10.1212/01.WNL.0000154641.08211.B7.
  • Cerebral Palsies Causes, Consequences, and ManagementMiller G, Clark GD (Eds): Cerebral Palsies Causes, Consequences, and Management. Boston, Butterworth and Heinemann, 1998
  • tatic Encephalopathies of Infancy and ChildhoodMiller G, Ramer JC (Eds): Static Encephalopathies of Infancy and Childhood. Raven Press, New York, 1992.
Edit Profile